Loading...
Found 67 hematology trials
A listing of hematology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
This study investigates the use of a web-based eHealth intervention as an alternative to traditional in-person genetic counseling for cancer genetic testing. The purpose of this study is to explore how this approach can provide necessary genetic testing information while maintaining the quality of care. The study aims to address …
To investigate the efficacy and expansion of CAR T-cells manufactured in an expedited fashion in patient-derived xenograft models (mice).
To determine potential mechanisms of CD20 loss after CD20-directed therapy in non-Hodgkin lymphomas.
Obtain patient information (name, age, gender, genetic testing information, OncoType Dx recurrence scores, breast cancer diagnosis information (hormone receptor status, TNM, histology), age at diagnosis) collected from the electronic medical record of approximately 70 patients to perform age-matched control analyses.
This study investigates ways to detect prostate cancer earlier in people at genetic risk for aggressive disease, which forms, grows, or spreads quickly. The purpose is to study samples of blood, urine, and tissue in the laboratory to better understand the genetics of prostate cancer. This research aims to identify …
We propose the use of 2 different study populations to first evaluate cancer access outcomes among patients enrolled in IMPaCT who subsequently receive a diagnosis of cancer, compared to University of Pennsylvania Health System administrative data of cancer patients not enrolled in IMPaCT who meet insurance and zipcode criteria; and …
To explore secondary malignancies in subjects enrolled to the L-RAD study (IRB #832203, Lymphoproliferative Disorders: Biological Specimen Repository and Clinical Database) who received CAR T-cells or other T-cell directed therapies for lymphoproliferative disorders and to investigate potential relationships between prior T-cell directed therapy for lymphoma and subsequent malignancies.
To identify novel gene and protein targets in biospecimens of patients with EBV-associated lymphoproliferative disorders who are enrolled to L-RAD (IRB #832203).
The objective is to obtain clinical (phenotypic) and laboratory (biomarker) data during immediate drug hypersensitivity reactions in L-RAD patients receiving anti-CD19 or anti-CD20 bispecific antibodies or monoclonal antibodies to classify them as a(an): (1) type 1 immediate hypersensitivity reaction (allergic) (2) cytokine release syndrome (CRS) (3) infusion-related reaction (IRR) (4) …
To develop PDX models or tumor cell lines of tumors from subjects with lymphoproliferative disorders enrolled to L-RAD (IRB #832203).
Please choose between Voice or SMS based delivery of verification code
or